News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
The partners will use mass spec to look at markers in Barrett's patients who either progressed to more severe disease states or remained stable over a 10-year period.
The company reported revenues of $627.5 million, up from $599.9 million in Q4 2019, and beating the consensus Wall Street estimate of $602.0 million.
The aim is to improve the accuracy of the protein measurements commonly reported as the output of proteomic experiments and uncover obscured biological signals.
The researchers identified phenotypes of SARS-CoV-2-specific T cells as well as viral epitopes involved in T cell response that could aid future vaccine design.
Waters' Q4 revenues were $786.7 million, up 10 percent from $716.3 million in Q4 2019, and above the consensus Wall Street estimate of $713.7 million.
